tiprankstipranks
Nektar Therapeutics (NKTR)
NASDAQ:NKTR
US Market

Nektar Therapeutics (NKTR) Income Statement

Compare
1,259 Followers

Nektar Therapeutics Income Statement

Last quarter (Q3 2024), Nektar Therapeutics's total revenue was $24.12M, a decrease of -0.08% from the same quarter last year. In Q3, Nektar Therapeutics's net income was $-37.06M. See Nektar Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 90.12M$ 92.06M$ 101.91M$ 152.91M$ 114.62M
Gross Profit
$ 53.48M$ 70.42M$ 77.01M$ 133.44M$ 93.24M
Operating Expenses
$ 190.90M$ 310.66M$ 523.11M$ 513.36M$ 533.28M
Depreciation and Amortization
$ 7.82M$ 12.20M$ 13.00M$ 12.50M$ 11.00M
EBITDA
$ -243.11M$ -323.87M$ -462.97M$ -394.33M$ -382.70M
Operating Income
$ -137.43M$ -240.24M$ -446.10M$ -379.92M$ -440.04M
Other Income/Expenses
$ -138.83M$ -124.75M$ -77.18M$ -64.03M$ -19.00K
Pretax Income
$ -276.26M$ -364.98M$ -523.28M$ -443.95M$ -440.05M
Net Income
$ -276.06M$ -368.20M$ -523.84M$ -444.44M$ -440.67M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.45$ -1.97$ -2.86$ -2.49$ -2.52
Diluted EPS
$ -1.45$ -1.97$ -2.86$ -2.49$ -2.52
Weighted Average Shares Outstanding
190.00M 187.14M 183.30M 178.58M 174.99M
Weighted Average Shares Outstanding (Diluted)
190.00M 187.14M 183.30M 178.58M 174.99M
Currency in USD

Nektar Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis